JP2022508236A5 - - Google Patents

Info

Publication number
JP2022508236A5
JP2022508236A5 JP2021529734A JP2021529734A JP2022508236A5 JP 2022508236 A5 JP2022508236 A5 JP 2022508236A5 JP 2021529734 A JP2021529734 A JP 2021529734A JP 2021529734 A JP2021529734 A JP 2021529734A JP 2022508236 A5 JP2022508236 A5 JP 2022508236A5
Authority
JP
Japan
Prior art keywords
montelukast
pharmaceutical composition
composition according
pharmaceutically acceptable
acceptable salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021529734A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022508236A (ja
JP7399502B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2019/082425 external-priority patent/WO2020109230A1/en
Publication of JP2022508236A publication Critical patent/JP2022508236A/ja
Publication of JP2022508236A5 publication Critical patent/JP2022508236A5/ja
Application granted granted Critical
Publication of JP7399502B2 publication Critical patent/JP7399502B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021529734A 2018-11-26 2019-11-25 びらん性変形性手関節症の治療のためのモンテルカスト Active JP7399502B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP18382851 2018-11-26
EP18382851.6 2018-11-26
PCT/EP2019/082425 WO2020109230A1 (en) 2018-11-26 2019-11-25 Montelukast for the treatment of erosive hand osteoarthritis

Publications (3)

Publication Number Publication Date
JP2022508236A JP2022508236A (ja) 2022-01-19
JP2022508236A5 true JP2022508236A5 (enExample) 2022-12-06
JP7399502B2 JP7399502B2 (ja) 2023-12-18

Family

ID=64665075

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021529734A Active JP7399502B2 (ja) 2018-11-26 2019-11-25 びらん性変形性手関節症の治療のためのモンテルカスト

Country Status (22)

Country Link
US (1) US12539296B2 (enExample)
EP (1) EP3886857B1 (enExample)
JP (1) JP7399502B2 (enExample)
CN (1) CN113347975B (enExample)
AU (1) AU2019386235B2 (enExample)
BR (1) BR112021009980A2 (enExample)
CA (1) CA3120920C (enExample)
DK (1) DK3886857T3 (enExample)
ES (1) ES2961390T3 (enExample)
FI (1) FI3886857T3 (enExample)
HR (1) HRP20231283T1 (enExample)
HU (1) HUE063579T2 (enExample)
MA (1) MA54276B1 (enExample)
MD (1) MD3886857T2 (enExample)
MX (1) MX2021006209A (enExample)
MY (1) MY203365A (enExample)
PL (1) PL3886857T3 (enExample)
PT (1) PT3886857T (enExample)
RS (1) RS64668B1 (enExample)
SI (1) SI3886857T1 (enExample)
TW (1) TWI850283B (enExample)
WO (1) WO2020109230A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4228641A1 (en) * 2020-10-13 2023-08-23 Diomed Developments Limited Gel formulations comprising montelukast
GB2599912B (en) * 2020-10-13 2023-04-19 Diomed Dev Ltd New formulation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201020085D0 (en) * 2010-11-26 2011-01-12 Xaragen Pharma Ltd Methods and reagents for the treatment of arthritic disorders
CA2931978A1 (en) 2013-12-02 2015-06-11 Abbvie Inc. Compositions and methods for treating osteoarthritis

Similar Documents

Publication Publication Date Title
JP2011068653A5 (enExample)
JP2013511507A5 (enExample)
JP2012031131A5 (enExample)
JP2016065086A5 (enExample)
JP2012031147A5 (enExample)
IL298998B1 (en) Pharmaceutical formulations of a hif hydroxylase inhibitor
JP2015534973A (ja) 抗レトロウイルス医薬組成物
JP2016516058A5 (enExample)
FI3710000T3 (fi) Tradipitantti käytettäväksi gastropareesin hoidossa
JP2018513171A5 (enExample)
HRP20220332T1 (hr) Farmaceutski pripravak koji sadrži drospirenon za uporabu kao kontraceptiv
JP2012533565A5 (enExample)
RU2014115287A (ru) Фармацевтическая композиция для перорального введения с маскированным вкусом и способ ее получения
JP2022508236A5 (enExample)
JP2019218379A5 (enExample)
JP2010524882A5 (enExample)
JP2015531749A5 (enExample)
JP2011516544A5 (enExample)
JP2019504024A5 (enExample)
FI3886857T3 (fi) Montelukasti erosiivisen käden nivelrikon hoitoon
JP2021504360A5 (enExample)
RU2018113801A (ru) Составы l-орнитин фенилацетата
JP2015120758A5 (enExample)
JP2016512493A5 (enExample)
HRP20220701T1 (hr) Spojeni benzazepini za liječenje touretteova sindroma